Blood‐based Alzheimer's disease biomarkers in a behavioral neurology clinic: Real‐world implementation, clinical utility, and diagnostic performance

Blood-based biomarkers (BBMs) were quickly adopted and accelerated precision diagnosis in a large memory clinic. BBM use cases were diverse and included all stages/types of AD and non-AD syndromes. Plasma p-tau has the potential to impact diagnostic certainty and clinical decision making. Diagnostic performance of p-tau is reasonable, though renal function impacts overall accuracy.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-11-01
DOI
https://doi.org/10.1002/alz.70891
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Blood‐based Alzheimer's disease biomarkers in a behavioral neurology clinic: Real‐world implementation, clinical utility, and diagnostic performance

Lawren VandeVrede, Julio C. Rojas, Adam M. Staffaroni, Renaud La Joie et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Blood‐based Alzheimer's disease biomarkers in a behavioral neurology clinic: Real‐world implementation, clinical utility, and diagnostic performance

Lawren VandeVrede, Julio C. Rojas, Adam M. Staffaroni, Renaud La Joie, Yingbing Wang, Peter Alexander Ljubenkov, Nhat Bui, Melanie L. Stephens, Bruce L. Miller, Elena Tsoy, Gil Dan Rabinovici, Gautam Tammewar, David N. Soleimani‐Meigooni, Manizhe Eslami‐Amirabadi, Igor Araújo, Kaancan Deniz, Charles Windon, Andrew G. Breithaupt, Katherine L. Possin, Connor D. Dietz, Marci F. Rosenberg, Adam L. Boxer, Y. González González, Tara Ellingson, Nicholas U. Schwartz
article en

Abstract

Blood-based biomarkers (BBMs) were quickly adopted and accelerated precision diagnosis in a large memory clinic. BBM use cases were diverse and included all stages/types of AD and non-AD syndromes. Plasma p-tau has the potential to impact diagnostic certainty and clinical decision making. Diagnostic performance of p-tau is reasonable, though renal function impacts overall accuracy.

Alzheimer s & DementiaVol. 21(11)
Emory University (US), University of California, San Francisco (US), University Memory and Aging Center (US)
Openalex Percentile: Top 60%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.